Michael Amoroso
Chief Executive Officer at PRECISION BIOSCIENCES, INC.
Net worth: 873 863 $ as of 2024-03-30
Michael Amoroso active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Chairman | 2021-10-13 | - |
| Director/Board Member | 2021-03-18 | 2021-10-13 | |
| Chief Executive Officer | 2021-03-18 | 2021-10-13 | |
| Chief Operating Officer | 2020-10-31 | 2021-03-18 | |
| Corporate Officer/Principal | 2020-07-08 | 2020-10-31 | |
| President | 2021-03-18 | 2021-10-13 | |
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 2021-10-14 | - |
| Chief Executive Officer | 2021-10-14 | - | |
| President | 2021-10-14 | - |
Career history of Michael Amoroso
Former positions of Michael Amoroso
| Companies | Position | Start | End |
|---|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 2018-07-31 | 2019-12-31 |
Training of Michael Amoroso
| Rider University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Michael Amoroso
- Experience
